Timing of Central Venous Line Insertion During Induction in Children With Acute Lymphoblastic Leukemia.

Autor:	Ataseven E; Division of Pediatric Hematology and Oncology, Department of Pediatric Hematology-Oncology, Ege University Faculty of Medicine., Yilmaz Ş; Department of Pediatric Hematology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey., Tüfekçi Ö; Department of Pediatric Hematology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey., Ören H; Department of Pediatric Hematology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
Jazyk:	angličtina
Zdroj:	Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2023 Jan 01; Vol. 45 (1), pp. 25-28. Date of Electronic Publication: 2022 Nov 24.
DOI:	10.1097/MPH.0000000000002600
Abstrakt:	Purpose: Central venous lines (CVL) in children with acute lymphoblastic leukemia (ALL) provide comfortable administration of intensive chemotherapy and blood sampling. The optimal time for the insertion of CVL in patients with ALL during induction therapy is controversial. This study aimed to investigate the frequency of CVL-related complications in children with ALL concerning the time of CVL insertion. Patients and Methods: We reviewed the records of 52 pediatric ALL patients with CVL. CVL placement before or on treatment day 15 was defined as "early insertion", and after treatment day 15 was defined as "late insertion". Demographics, preoperative blood counts, type of central line, time of CVL placement, CVL-related complications, and blood counts during complications were all noted. All the data were collected from those with the first catheter use. Results: CVL was placed ≤15 days in 26 patients (50%) and after 15 days in 26 patients (50%). Regarding the infection rates, no statistical difference was found between early and late CVL-inserted groups ( P =n.s.). Five patients developed thrombosis, and risk was found to be similar between early and late CVL-inserted groups ( P =n.s.). Catheter-related mechanical complications were recorded in 7 patients (3 in early and 4 in late CVL-inserted group, ( P =n.s.). Conclusion: The present study showed no relation between the timing of CVL placement during induction therapy and the occurrence of infection and thrombosis. Our results suggest that CVL can be placed safely at the time of diagnosis or early induction treatment to provide a comfortable administration of chemotherapy and decrease painful blood samplings. Competing Interests: The authors declare no conflict of interest. (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu